# ZD MEDTECH

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zd-medtech

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.zdmedtech.com
- Total disclosed funding: $15M
- Latest round: Series B (Feb 15, 2023)
- Investors on record: 6

## About

Based in Shanghai, China and established in 2015, ZD MEDTECH operates as a developer of rehabilitation robots that develops, manufactures rehabilitation robots, and provides intelligent rehabilitation solutions. There are more than 100 employees in the company. ZD MEDTECH was awarded as a High-tech Enterprise in Shanghai, the Drafting Unit of National Standard for Upper Limb Rehabilitation Training Robot and Yangpu Entrepreneurial Star. Several universities and hospital institutions, such as Fudan University, Shanghai Jiao Tong University, China Disabled Persons' Federation, Zhongshan Hospital of Fudan University, China Rehabilitation Research Center and Shanghai First Rehabilitation Hospital, have cooperated with the ocmpany.

ZD MEDTECH focuses on the development and application of rehabilitation training robots and intelligent rehabilitation solutions. The company's main product is Nimbot, an upper limb rehabilitation training robot, which can be used for the rehabilitation of patients with upper limb movement disorders caused by stroke and traumatic brain injury. ZD MEDTECH also launched a comprehensive solution for intelligent rehabilitation, Jodo Smart Ark. Intelligent rehabilitation integrated solutions cover OT and upper limb rehabilitation solutions, PT and lower limb rehabilitation solutions, including dozens of global leading technology rehabilitation robots and intelligent software and hardware.

The company is expected to add more than ten innovative products to the market within two years.

## Funding rounds

- Series B, Feb 15, 2023, $15M — Shunwei Capital, Redhill Capital, Hengxu Capital
- Series A, Jan 4, 2021 — Shanghai Zhangjiang Science & Technology Venture Capital, Legend Star
- Angel, Jun 9, 2017 — HiMed Angle Fund Management

## Investors

- HiMed Angle Fund Management (https://capitalatlas.ai/funds/himed-angle-fund-management) — Angel
- Shanghai Zhangjiang Science & Technology Venture Capital — Series A
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A
- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Series B
- Redhill Capital (https://capitalatlas.ai/funds/redhill-capital) — Series B
- Hengxu Capital (https://capitalatlas.ai/funds/hengxu-capital) — Series B
